Showing results (91-100 of 134) with videos related to

Sort By:
Pageof 14
Immunotherapy|June 5, 2025
Prognostic value of serum albumin-creatinine ratio as a biomarker in patients treated with immune checkpoint inhibitorsOnur Bas, Mert Tokatlı, Naciye Guduk, et al.
Clinical & Experimental Metastasis|June 28, 2026
Safety evaluation of TOPAZ-1 and KEYNOTE-966 regimens in metastatic biliary tract cancer: a systematic review and meta-analysisElsa Vitale, Lorenza Maistrello, Francesco Ciccimarra, et al.
Journal of Clinical Medicine|May 14, 2025
Early Changes in Volumetric Body Composition Parameters Predict Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma Treated with Targeted TherapyOktay Halit Aktepe, Ahmet Gurkan Erdemir, Eda Caliskan Yildirim, et al.
BMJ Supportive & Palliative Care|September 4, 2021
Sarcopenia and anthracycline cardiotoxicity in patients with cancerOnur Bas, Ahmet Gurkan Erdemir, Mehmet Ruhi Onur, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|December 24, 2022
The association between pan-immune-inflammation value and survival in head and neck squamous cell carcinomaDeniz Can Guven, Enes Erul, Feride Yilmaz, et al.
Digital Health|February 2, 2026
Enhancing early prediction of pathological complete response in breast cancer using attention-based convolutional neural networks in digital pathologyMaria Colomba Comes, Andrea Lupo, Arianna Bozzi, et al.
Journal of Clinical Medicine|March 27, 2025
Comparative Analysis of Prognostic Potential of Pretreatment Blood-Based Biomarkers in Metastatic Bladder Cancer: Modified Glasgow Prognostic ScoreFatih Kus, Deniz Can Guven, Hasan Cagri Yildirim, et al.
Scientific Reports|November 23, 2023
Comparison between vision transformers and convolutional neural networks to predict non-small lung cancer recurrenceAnnarita Fanizzi, Federico Fadda, Maria Colomba Comes, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|November 11, 2021
Efficacy analyses of axitinib and nivolumab in metastatic renal cell carcinoma after failure of targeted therapy: which is better?Oktay Halit Aktepe, Fadime Sinem Ardic, Deniz Yuce, et al.
Immunotherapy|June 27, 2025
Albumin-myosteatosis gauge as a prognostic biomarker in patients treated with immune checkpoint inhibitorsTaha Koray Sahin, Deniz Can Guven, Yakup Ozbay, et al.
Pageof 14